577
Participants
Start Date
October 31, 2019
Primary Completion Date
January 30, 2020
Study Completion Date
August 30, 2022
Flublok™ Quadrivalent by Sanofi, Inc.
0.5 mL intramuscular dose of Flublok
VaxigripTetra™ by Sanofi, Inc.
0.5 mL intramuscular dose of Vaxigrip
Soroka Medical Center, Beersheba
Rabin Medical Center-Beilinson, Petah Tikva
Collaborators (2)
Abt Associates
INDUSTRY
Clalit Research Institute
OTHER
Soroka University Medical Center
OTHER
Rabin Medical Center
OTHER
University of Michigan
OTHER
Centers for Disease Control and Prevention
FED